RP for High risk patients?

[Manuel]

I would say they say yes...

Long-term outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivation - Abstract
Wednesday, 24 March 2010

At 5 and 10 years, cancer-specific survival was 91.3 and 87.2%; overall survival was 84.3 and 72.1%; biochemical progression-free survival (BPFS) was 76.6 and 56.2%; clinical progression-free survival was 86.2 and 79.9%.

http://www.urotoday.com/61/browse_categ ... 42010.html